Cadila Healthcare informs about outcome of board meeting

16 Mar 2020 Evaluate

In continuation to earlier intimation dated March 11, 2020 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Cadila Healthcare has informed that the Board of Directors at its meeting held today, March 16, 2020 approved payment of interim dividend at of 350 %, that is, Rs 3.50 per equity share on 102,37,42,600 Equity Shares of Re 1 each of the Company for the Financial Year 2019-2020. The Board of Directors has confirmed Tuesday, March 24, 2020 as the Record Date to ascertain the list of members entitled to receive the interim dividend declared by the Board of Directors. Further, the interim dividend shall be paid to the shareholders entitled thereto, on and from March 27, 2020. The Dividend cheques would be posted on or after March 30, 2020 and within 30 days from the date of declaration of dividend as provided in the Companies Act, 2013. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

890.20 0.00 (0.00%)
30-Jan-2026 09:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1592.90
Dr. Reddys Lab 1210.95
Cipla 1318.60
Zydus Lifesciences 890.20
Lupin 2154.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×